Erdheim–Chester disease: A systematic review
Top Cited Papers
- 1 July 2015
- journal article
- case report
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 95 (1), 1-11
- https://doi.org/10.1016/j.critrevonc.2015.02.004
Abstract
No abstract availableKeywords
Funding Information
- Italian Association for Cancer Research (IG11647)
- Italian Ministry for the University and Research (PRIN 2010)
This publication has 39 references indexed in Scilit:
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseBlood, 2014
- Erdheim-Chester Disease: Characteristics and ManagementMayo Clinic Proceedings, 2014
- Erdheim–Chester DiseaseCurrent Rheumatology Reports, 2014
- New Insights Into the Molecular Pathogenesis of Langerhans Cell HistiocytosisThe Oncologist, 2014
- Erdheim-Chester Disease: a comprehensive review of the literatureOrphanet Journal of Rare Diseases, 2013
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationBlood, 2013
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new casesAnnals Of The Rheumatic Diseases, 2013
- Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With InfliximabJournal of Clinical Oncology, 2012
- High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytosesBlood, 2012
- Erdheim–Chester diseaseCurrent Opinion in Rheumatology, 2012